Literature DB >> 12865521

Secondary holocord syringomyelia with spinal hemangioblastoma: a report of two cases.

S B Pai1, K N Krishna.   

Abstract

Intramedullary spinal hemangioblastoma is well known to be accompanied by syringomyelia. However, holocord secondary syringomyelia is uncommon. We present 2 cases of spinal hemangioblastoma, one in the conus medullaris and the other in midthoracic region, accompanied by holocord syrinx. In both the cases the secondary syrinx resolved following successful total tumor excision with good neurological recovery.

Entities:  

Mesh：

Year:  2003        PMID： 12865521

Source DB:  PubMed          Journal:  Neurol India        ISSN： 0028-3886            Impact factor:   2.117


  5 in total

1.  Spinal hemangioblastomas: analysis of surgical outcome and prognostic factors.

Authors:  Alberto Feletti; Alessandro Boaro; Davide Giampiccolo; Giorgio Casoli; Fabio Moscolo; Massimiliano Ferrara; Francesco Sala; Giacomo Pavesi
Journal:  Neurosurg Rev       Date:  2021-11-25       Impact factor: 3.042

2.  Multiple VHL-related hemangioblastomas and holocord syrinx: identifying the causative lesion. Illustrative case.

Authors:  Armin Mortazavi; Diana Nwokoye; David T Asuzu; Gretchen Scott; Panagiotis Mastorakos; Prashant Chittiboina
Journal:  J Neurosurg Case Lessons       Date:  2021-09-13

Review 3.  Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

4.  Dorsal hemangioblastoma manifesting as holocord syringomyelia.

Authors:  Gautam Dutta; Daljit Singh; Hukum Singh; Arvind K Srivastava; Anita Jagetia; Atul Agrawal
Journal:  Surg Neurol Int       Date:  2018-04-05

5.  Combined Microsurgery and Radiotherapy for Multiple Spinal Cord Hemangioblastomas with Holocord Syrinx in von Hippel-Lindau Disease: A Case Report.

Authors:  Nicolas Knoop; Clemens Seidel; Clara Frydrychowicz; Jürgen Meixensberger
Journal:  J Neurol Surg Rep       Date:  2019-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.